Lv1
100 积分 2024-03-10 加入
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
6小时前
待确认
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary
7小时前
已完结
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors
16小时前
已完结
Histopathological and immunohistochemical features of cutaneous and oral immune-related adverse events associated with PD-1 inhibitor therapy
3天前
求助中
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
3天前
已完结
Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review
4天前
已完结
Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy
5天前
已完结
Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review
5天前
已完结
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases
14天前
已完结
皖公网安备34019202002308
